Publications by authors named "Hagop M Kantarjian"

100Publications

Prognostic value of blasts in peripheral blood in myelofibrosis in the ruxolitinib era.

Cancer 2020 Jul 22. Epub 2020 Jul 22.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.33094DOI Listing
July 2020

The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor types.

Cancer 2020 Jul 13;126(14):3192-3201. Epub 2020 May 13.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32909DOI Listing
July 2020

New drug approvals in oncology.

Nat Rev Clin Oncol 2020 03 4;17(3):140-146. Epub 2020 Feb 4.

Friends of Cancer Research, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-019-0313-2DOI Listing
March 2020

t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?

Ann Hematol 2020 Mar 31;99(3):487-500. Epub 2020 Jan 31.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 0072, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-020-03909-7DOI Listing
March 2020

Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management.

Cancer 2020 03 3;126(6):1152-1160. Epub 2019 Dec 3.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32606DOI Listing
March 2020

Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients With Gram-Negative Bacteremia.

Open Forum Infect Dis 2019 Oct 28;6(10):ofz357. Epub 2019 Sep 28.

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofz357DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765346PMC
October 2019

Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia.

Br J Haematol 2020 01 30;188(2):207-223. Epub 2019 Sep 30.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16207DOI Listing
January 2020

Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia.

Clin Epigenetics 2019 07 22;11(1):106. Epub 2019 Jul 22.

Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13148-019-0704-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647096PMC
July 2019

SOHO State of the Art Update and Next Questions: Advances in the Treatment of Adult Acute Lymphoblastic Leukemia.

Clin Lymphoma Myeloma Leuk 2019 08 3;19(8):471-479. Epub 2019 Jul 3.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.06.011DOI Listing
August 2019

Reply to Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope?

Cancer 2019 11 10;125(21):3891-3892. Epub 2019 Jul 10.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32385DOI Listing
November 2019

Philadelphia chromosome-negative acute leukemia in patients with chronic myeloid leukemia.

Am J Hematol 2019 10 28;94(10):E256-E259. Epub 2019 Jul 28.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25571DOI Listing
October 2019

Treatment value of second-generation BCR-ABL1 tyrosine kinase inhibitors compared with imatinib to achieve treatment-free remission in patients with chronic myeloid leukaemia: a modelling study.

Lancet Haematol 2019 Aug 14;6(8):e398-e408. Epub 2019 Jun 14.

Department of Leukemia, MD Anderson Cancer Center, University of Texas, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30087-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658341PMC
August 2019

Inotuzumab ozogamicin, a nonchemotherapy option for relapsed acute lymphoblastic leukemia.

Clin Adv Hematol Oncol 2019 May;17(5):268-270

The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
May 2019

Recent advances in the treatment of acute lymphoblastic leukemia.

Leuk Lymphoma 2019 11 16;60(11):2606-2621. Epub 2019 May 16.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1605071DOI Listing
November 2019

Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.

N Engl J Med 2019 04;380(17):1628-1637

From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana-Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) - all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham, NC (D.A.R.); and Roswell Park Comprehensive Cancer Center, Buffalo (E.S.W.), and Stemline Therapeutics, New York (S. Spence, S. Shemesh, C.L.B., I.B.) - both in New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1815105DOI Listing
April 2019

Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy.

Oncotarget 2019 Feb 8;10(12):1250-1265. Epub 2019 Feb 8.

The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26579DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383813PMC
February 2019

How much of US health care spending provides direct care or benefit to patients?

Cancer 2019 05 29;125(9):1404-1409. Epub 2019 Jan 29.

College of Medicine, University of South Alabama, Mobile, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31865DOI Listing
May 2019

The opioid epidemic in the United States-Overview, origins, and potential solutions.

Cancer 2018 11 9;124(22):4279-4286. Epub 2018 Oct 9.

Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31713
Publisher Site
http://dx.doi.org/10.1002/cncr.31713DOI Listing
November 2018

Toward the potential cure of leukemias in the next decade.

Cancer 2018 11 6;124(22):4301-4313. Epub 2018 Oct 6.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31669
Publisher Site
http://dx.doi.org/10.1002/cncr.31669DOI Listing
November 2018

Reply to Starting with a lower daily dose of dasatinib in patients with chronic myeloid leukemia in chronic phase: Less is more, or is it?

Cancer 2018 11 1;124(21):4261. Epub 2018 Oct 1.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31683
Publisher Site
http://dx.doi.org/10.1002/cncr.31683DOI Listing
November 2018

Prognostic significance of hyperdiploidy in adult acute myeloid leukemia.

Am J Hematol 2018 11 9;93(11):E357-E360. Epub 2018 Sep 9.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25240DOI Listing
November 2018

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

N Engl J Med 2018 Jun 2;378(25):2386-2398. Epub 2018 Jun 2.

From the University of Texas M.D. Anderson Cancer Center, Houston (C.D.D., H.M.K.); Memorial Sloan Kettering Cancer Center (E.M.S., M.S.T.) and Weill Cornell Medical College (G.J.R.), New York; Institut Gustave Roussy, Villejuif (S.B., C.W.), and Centre Hospitalier Universitaire Bordeaux, Bordeaux (A.P.) - both in France; Northwestern University, Chicago (J.K.A.); Ohio State University Wexner Medical Center, Columbus (A.S.M.); Sylvester Comprehensive Cancer Center, University of Miami, Miami (R.S.); University of Texas Southwestern Medical Center, Dallas (R.H.C.); University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco (G.N.M.), and City of Hope Medical Center, Duarte (A.S.S.) - both in California; University of Colorado School of Medicine, Aurora (D.A.P.); Sarah Cannon Research Institute, Nashville (W.D.); Massachusetts General Hospital Cancer Center (A.T.F.) and Dana-Farber Cancer Institute (R.M.S.), Boston, and Agios Pharmaceuticals, Cambridge (S.C., H.W., V.Z., K.E.Y., S.M.K., H.Y., D.D., B.F., M.G., H.L., S.A., B.W., E.C.A.) - all in Massachusetts; University of Alabama at Birmingham, Birmingham (H.P.E.); Johns Hopkins University, Baltimore (G.T.P.); Washington University School of Medicine, St. Louis (G.L.U.); Mayo Clinic, Jacksonville, FL (J.M.F.); Oregon Health and Science University Knight Cancer Institute, Portland (E.T.); Hollings Cancer Center, Medical University of South Carolina, Charleston (R.K.S.); Winship Cancer Institute of Emory University, Atlanta (M.L.A.); Mayo Clinic, Phoenix, AZ (J.L.S.); and Cleveland Clinic, Cleveland (M.A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1716984DOI Listing
June 2018